These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

874 related articles for article (PubMed ID: 22807098)

  • 61. The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension.
    Weber MA; Kirtane AJ; Weir MR; Radhakrishnan J; Das T; Berk M; Mendelsohn F; Bouchard A; Larrain G; Haase M; Diaz-Cartelle J; Leon MB
    JACC Cardiovasc Interv; 2020 Feb; 13(4):461-470. PubMed ID: 32081240
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications.
    Ayala DE; Hermida RC; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):340-52. PubMed ID: 23077973
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term verification of functional and structural renal damage after renal sympathetic denervation.
    Dörr O; Liebetrau C; Möllmann H; Gaede L; Troidl C; Wiebe J; Renker M; Bauer T; Hamm C; Nef H
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1298-303. PubMed ID: 26699846
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Catheter-based radiofrequency renal sympathetic denervation for resistant hypertension.
    Damascelli B; Patelli G; Tichá V; Della Rocca F; Lattuada S; Sala C; Albertoni A; D'Alessio A; Funaro A; Scotti L
    J Vasc Interv Radiol; 2013 May; 24(5):632-9. PubMed ID: 23622036
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Renal denervation for mild-moderate treatment-resistant hypertension : A timely intervention?
    Chen S; Kiuchi MG; Schmidt B; Hoye NA; Acou WJ; Liu S; Chun KRJ; Pürerfellner H
    Herz; 2019 Aug; 44(5):412-418. PubMed ID: 29255910
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impact of local vascular lesions assessed with optical coherence tomography and ablation points on blood pressure reduction after renal denervation.
    Ghadri JR; Gaehwiler R; Jaguszewski M; Sudano I; Osipova J; Schoenenberger-Berzins R; Erne P; Lüscher TF; Templin C
    Swiss Med Wkly; 2015; 145():w14102. PubMed ID: 25658048
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Twenty-four hour ambulatory blood pressure for the management of antihypertensive treatment: a randomized controlled trial.
    Conen D; Tschudi P; Martina B
    J Hum Hypertens; 2009 Feb; 23(2):122-9. PubMed ID: 18754021
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The randomised Oslo study of renal denervation
    Bergland OU; Søraas CL; Larstorp ACK; Halvorsen LV; Hjørnholm U; Hoffman P; Høieggen A; Fadl Elmula FEM
    Blood Press; 2021 Feb; 30(1):41-50. PubMed ID: 33030064
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Unilateral catheter-based renal sympathetic denervation in resistant arterial hypertension shows no blood pressure-lowering effect.
    Václavík J; Táborský M; Richter D
    Clin Exp Hypertens; 2013; 35(3):192-4. PubMed ID: 22891761
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Renal artery sympathetic denervation: observations from the UK experience.
    Sharp AS; Davies JE; Lobo MD; Bent CL; Mark PB; Burchell AE; Thackray SD; Martin U; McKane WS; Gerber RT; Wilkinson JR; Antonios TF; Doulton TW; Patterson T; Clifford PC; Lindsay A; Houston GJ; Freedman J; Das N; Belli AM; Faris M; Cleveland TJ; Nightingale AK; Hameed A; Mahadevan K; Finegold JA; Mather AN; Levy T; D'Souza R; Riley P; Moss JG; Di Mario C; Redwood SR; Baumbach A; Caulfield MJ; Dasgupta I
    Clin Res Cardiol; 2016 Jun; 105(6):544-52. PubMed ID: 26802018
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Transurethral Renal Pelvic Denervation: A Feasibility Trial in Patients with Uncontrolled Hypertension.
    Hering D; Nikoleishvili D; Imedadze A; Dughashvili G; Klimiashvili Z; Bekaia E; Shengelia T; Kobalava M; Goguadze O; Emukhvari T; Druker V; Sackner-Bernstein J; Weber MA
    Hypertension; 2022 Dec; 79(12):2787-2795. PubMed ID: 36254733
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.
    Schlaich MP; Bart B; Hering D; Walton A; Marusic P; Mahfoud F; Böhm M; Lambert EA; Krum H; Sobotka PA; Schmieder RE; Ika-Sari C; Eikelis N; Straznicky N; Lambert GW; Esler MD
    Int J Cardiol; 2013 Oct; 168(3):2214-20. PubMed ID: 23453868
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension (RADIOSOUND-HTN).
    Fengler K; Rommel KP; Blazek S; Besler C; Hartung P; von Roeder M; Petzold M; Winkler S; Höllriegel R; Desch S; Thiele H; Lurz P
    Circulation; 2019 Jan; 139(5):590-600. PubMed ID: 30586691
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial.
    Kandzari DE; Böhm M; Mahfoud F; Townsend RR; Weber MA; Pocock S; Tsioufis K; Tousoulis D; Choi JW; East C; Brar S; Cohen SA; Fahy M; Pilcher G; Kario K;
    Lancet; 2018 Jun; 391(10137):2346-2355. PubMed ID: 29803589
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The effect of catheter based renal synthetic denervation on renin-angiotensin-aldosterone system in patients with resistant hypertension].
    Wang L; Lu CZ; Zhang X; Luo D; Zhao B; Yu X; Xia DS; Chen X; Zhao XD
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jan; 41(1):3-7. PubMed ID: 23651959
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Renal sympathetic denervation in hypertension.
    Doumas M; Faselis C; Papademetriou V
    Curr Opin Nephrol Hypertens; 2011 Nov; 20(6):647-53. PubMed ID: 21885968
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension.
    Brandt MC; Reda S; Mahfoud F; Lenski M; Böhm M; Hoppe UC
    J Am Coll Cardiol; 2012 Nov; 60(19):1956-65. PubMed ID: 23062529
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation.
    Schmieder RE; Ott C; Schmid A; Friedrich S; Kistner I; Ditting T; Veelken R; Uder M; Toennes SW
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873693
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Renal denervation as therapy for hypertension: potentials and unanswered questions.
    Vink EE; Bots ML; Blankestijn PJ
    Eur J Prev Cardiol; 2013 Dec; 20(6):980-91. PubMed ID: 23610453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.